Western Blotting Processors Market is Expected to Hit US$ 329 Million by 2028

VALLEY COTTAGE, New York, September 10, 2018 /PRNewswire/ --

Conventional western blotting processors are relatively inconsistent in terms of the efficiency of detecting protein traces in samples. While the technique of western blotting demands time and technical expertise, automation has magnified the process of throughput screening in western blotting, thereby facilitating increasing number of trials and accelerating the experimentation process. Automated western blotting techniques enable the analysis of several samples at one go, with the only manual task being loading of the sample into the western blotting system. Automation is currently trending the western blotting processors market, as revealed in a comprehensive research study by Future Market Insights.

     (Logo: https://mma.prnewswire.com/media/677274/Future_Market_Insights_Logo.jpg )

From an estimated valuation of US$ 200 Mn in 2018, the western blotting processors market is projected to reach a market value of just under US$ 329 Mn towards the close of 2028, exhibiting a decadal CAGR of 5.1%, according to the research report by Future Market Insights.

Manufacturers of Western Blotting Processors Accelerating Product Launches and Eyeing Offshoring as a Viable Growth Strategy 

The market for western blotting processors is highly competitive with the top companies accounting for a larger part of global sales. Leading companies are acquiring smaller companies and expanding their production capacities to gain a larger share of the global market.

Companies in the western blotting processors market are leveraging the available market opportunities to launch their products in full gear in the global market. One of the market companies leveraged an unexploited demand for point-of-care HIV diagnostics as its key entry strategy in the western blotting processors market. Product registration followed by commercialisation is accelerating the product launch process and creating healthy competition in the global market for western blotting processors.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-7365

Manufacturers of western blotting processors are setting up production facilities in other countries so as to benefit from access to cheap labour and resource expertise, and realign their distribution and customer oriented strategies. Another key player in the western blotting processors market recently made a strategic investment in the offshore development of its life sciences facility with a mandate to engage in the manufacturing and distribution of molecular biology products to a global clientele.

Increasing Global Cases of HIV and Expanding Applications Across Industries to Augment Revenue Growth of the Western Blotting Processors Market 

The number of HIV cases across the world is increasing by the day, causing a burden on the global healthcare industry. Monitoring and controlling the HIV epidemic depends on early detection of anti-HIV antibodies in human blood. Western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples. This is one of the factors leading to an increase in the adoption of western blotting processors.

Proteomics is extensively used in the pharmaceuticals industry to identify specific proteins associated with particular diseases, with western blotting finding application in new drug discovery. In the field of medical diagnostics, proteomics is used in the diagnosis of biomarkers that are essentially proteins present in body fluids. Western blotting helps in quick diagnosis of diseases by identifying proteins that are produced when the human body contracts a disease. Besides the healthcare and pharmaceuticals industry, western blotting also finds application in the agriculture sector to establish protein characterisation in seed quality testing; and in the food and beverages industry to detect whey milk protein in commercial grade soy milk to check for possible adulteration.

Preview Analysis Global Western Blotting Processors Market Segmentation By product type (Automated Dry Blotting Systems, Semi-Dry Blotting Systems, Traditional Wet Transfer Blotting Systems); by Application Type (Agricultural Application, Food & Beverages, Medical Diagnostics, Scientific Research, Other Applications); by End user Type (Diagnostic laboratories, Pharmaceutical and Biotechnology Companies, Research & Academic institution, others): https://www.futuremarketinsights.com/reports/western-blotting-processors-market

Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices 

Advanced automated western blotting devices such as the high performance western blotting transfer system are highly priced than their traditional counterparts, thereby restricting adoption across several developing economies. High cost of labour is another challenge in certain regions that continue to carry out protein tests using cheap traditional western blotting processors, thereby leading to time-consuming and high labour cost-inducing processes. Then again, the global western blotting processors market has not witnessed notable innovation, with very few advanced products launched in recent years. Further, results obtained from the western blotting process are not fully reliable or consistent and the devices need to be updated regularly to produce more efficient and reliable results. The aforementioned factors are challenging revenue growth of the global western blotting processors market.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-7365

More from FMI's Healthcare, Pharmaceuticals and Medical Devices 

• Analgesics Market Segmentation By Drug Class- opioids, non-steroidal anti-inflammatory drugs (NSAIDs), local anaesthetics and acetaminophen; Pain Type -surgical pain, cancer pain, neuropathic pain; Distribution Channel- hospital pharmacies, retail pharmacies, drug stores, clinics: https://www.futuremarketinsights.com/reports/analgesics-market
• Injectable Drug Delivery Market Segmentation By Product Type - Self-Injectors, Needle-free Injectors, Auto-Injectors; Usage - Disposable Injectors, Reusable Injectors: https://www.futuremarketinsights.com/reports/injectable-drug-delivery-market
• Carpal Tunnel Release Systems Market Segmentation by Product Type - open carpal tunnel release system and endoscopic carpal tunnel release system: https://www.futuremarketinsights.com/reports/carpal-tunnel-release-market

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More Healthcare, Pharmaceuticals and Medical devices

Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com

FMI Blog: http://www.fmiblog.com/
Website: www.futuremarketinsights.com